Literature DB >> 33567197

Regulatory T Cells in Multiple Sclerosis.

Joan M Goverman1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33567197     DOI: 10.1056/NEJMcibr2033544

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

Review 1.  What Have Failed, Interrupted, and Withdrawn Antibody Therapies in Multiple Sclerosis Taught Us?

Authors:  Julia Krämer; Heinz Wiendl
Journal:  Neurotherapeutics       Date:  2022-07-06       Impact factor: 6.088

2.  Cerebrospinal fluid cells immune landscape in multiple sclerosis.

Authors:  Yongchao Liu; Aili Jia; Zijian Li; Yueran Cui; Juan Feng
Journal:  J Transl Med       Date:  2021-03-25       Impact factor: 5.531

3.  The current standing of autologous haematopoietic stem cell transplantation for the treatment of multiple sclerosis.

Authors:  A G Willison; T Ruck; G Lenz; H P Hartung; S G Meuth
Journal:  J Neurol       Date:  2022-04-11       Impact factor: 4.849

Review 4.  Multimodal Benefits of Exercise in Patients With Multiple Sclerosis and COVID-19.

Authors:  Omid Razi; Bakhtyar Tartibian; Ismail Laher; Karuppasamy Govindasamy; Nastaran Zamani; Silvia Rocha-Rodrigues; Katsuhiko Suzuki; Hassane Zouhal
Journal:  Front Physiol       Date:  2022-04-14       Impact factor: 4.755

5.  Combined Regulatory T-Lymphocyte and IL-2 Treatment Is Safe, Tolerable, and Biologically Active for 1 Year in Persons With Amyotrophic Lateral Sclerosis.

Authors:  Jason R Thonhoff; James D Berry; Eric A Macklin; David R Beers; Patricia A Mendoza; Weihua Zhao; Aaron D Thome; Fabio Triolo; James J Moon; Sabrina Paganoni; Merit Cudkowicz; Stanley H Appel
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2022-08-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.